4D Molecular Therapeutics Stock (NASDAQ: FDMT)

Dernières nouvelles pour 4D Molecular Therapeutics (NASDAQ:FDMT) Stock

4D Molecular Therapeutics

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics Inc

Macro Economic Events

News

Econ #s

Economics

US Redbook (YoY) 5.3% Vs 5.7% Prior

Hedge Funds

General

Elliott Investment Management Discloses $2.5B+ Position In Phillips 66 And Sends Letter To Board

DOMH

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

ENV105 can potentially address resistance in a wide range of cancers as they become resistant to standard treatments.

Biotech

KAPA

Kairos Pharma Adds Huntsman Cancer Institute For Phase 2 Clinical Trial Of ENV105

WIIM

LIXT

Lixte Biotechnology shares are trading lower after the company announced a registered direct offering valued at approximately $1.05 million.

JP Morgan analyst Peter Peng maintains Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) with a Overweight and lowers the price target from $42 to $30.

Price Target

Analyst Ratings

AMKR

JP Morgan Maintains Overweight on Amkor Tech, Lowers Price Target to $30

HTBI

HomeTrust Bancshares,To Transfer Listing To NYSE; To Change Ticker To "HTB"

LIPO

Lipella Pharmaceuticals shares are trading higher after the company announced a favorable safety profile for its Phase 2a results of LP-310 for the treatment of oral lichen planus.

HYLN

Hyliion Signs LOI With Al Khorayef To Deploy KARNO Generators In Saudi Arabia

Good Morning Traders! In today&#8217;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#8217;s pulse to optimize your trading gains. Now, let&#8217;s dive into the stock analysis:
SPDR S&amp;P 500 ETF Trust ( SPY)
The SPY is currently trading near our level of 603.38. Bulls will want to see strength above this level, leading to a push toward 604.45. If buyers can maintain control, the next upside target is 605.41. A strong continuation could see the price test 606.34. If momentum holds, our high bull target for the session is 607.55.
Should 603.38 fail to act as support, bears will likely press the price lower toward 602.37. Continued selling pressure could drive a test of 601.22. If this level fails to hold, we have a significant support level at 600.51. In the event of an aggressive sell-off, our downside target for the session is 599.24.
Invesco QQQ Trust Series 1 (QQQ)
The QQQ is currently trading near our key level of 527.03. If bulls can hold this level, we expect a push toward 528.44. Holding this as support may bring further upside to 530.70. Continued strength in the market could drive a test of 532.52. If momentum persists, our high bull target for today is 533.70.
If 527.03 does not hold during the session, sellers will likely push toward 525.19. A break of this level could bring further downside to 523.91. If bears remain in control, we may see a test of 522.57. In a heavy sell-side scenario, our low bear target for today is 521.15.
Apple Inc. (AAPL)
Apple is currently auctioning near 226.90, which is an important level for the bulls to maintain. If buyers step in, we should see a push to 227.82, with strong momentum potentially driving the price up to 229.03. Continued demand could take Apple toward 230.25, which serves as the high bull target for today's session.
If 226.90 does not hold as support, a drop to 226.08 is likely. Weakness below this level could bring sellers into control, leading to a move down to 225.31. If bearish pressure intensifies, Apple may test 223.87, with the ultimate downside target for the day set at 222.96.
Microsoft Corp. (MSFT)
Microsoft is currently near 411.72, a level we want to see held for bullish continuation. If buyers sustain momentum above this mark, the next upside target is 413.14. Further strength in the auction could push the price to 414.56, with continued bullish activity leading to our high target for the day at 416.32.
If 411.72 is lost, sellers will aim for a test of 410.64. A move below this level could bring 409.69 into play, and if weakness persists, Microsoft may slide further to 408.46. In the event of a strong sell-off, the low bear target for today sits at 407.11.
NVIDIA Corporation (NVDA) NVIDIA is currently trading around 133.31, a key level that bulls need to defend. If buyers can hold this area, we anticipate a push up to 134.56, with continued demand potentially driving the price to 135.64. If momentum remains strong, NVIDIA could extend its rally to 136.98, with the high target for today resting at 137.94.
Should 133.31 fail as support, we expect sellers to push NVIDIA down to 132.19. A breakdown of this level could lead to a test of 131.42. If weakness in the market persists, further selling may drive the price to 129.53, with the low bear target for the session set at 128.10.
Alphabet Inc Class A (GOOGL)
Alphabet is currently trading near 186.02, a critical level in today's auction. If bulls can establish support here, we anticipate a move to 186.68. A break above this level could see buyers targeting 187.47. Should bullish momentum persist, our high bull target for the day is 188.73.
If 186.02 is lost, sellers will look to take control, driving the price down to 184.52. Continued weakness may lead to a test of 183.40. If this level fails to hold, increased selling pressure could bring the price down to our low target of 181.77.
Meta Platforms Inc (META)
Meta is currently auctioning around 716.39, a key level to watch. Bulls need to maintain strength above this point for a move to 717.87. A successful hold above this area could drive Meta higher to 720.11. If momentum remains on the buy-side, we anticipate the price reaching our high bull target at 721.50.
If 716.39 does not hold, bears will likely push Meta down to 712.14. A break below this level could bring additional weakness, leading to a test of 708.06. If sell-side pressure remains strong, the final downside target for today is 704.07.
Tesla Inc. (TSLA)
Tesla is currently trading around 346.64, which serves as an important level for today's session. If bulls can maintain strength, we expect an initial move to 350.87. A continuation of buy-side pressure could send Tesla higher to 356.80. Should demand remain strong, our high target for today is 370.22.
If 346.64 fails to hold as support, we anticipate a drop to 340.97. Continued selling pressure could push Tesla lower to 333.93. If this level does not hold, the final bear target for the session is 327.59.
Final Word: All eyes are on Fed Chair Jerome Powell's testimony before the Senate Banking Committee at 10AM ET, which will be closely analyzed for monetary policy signals. His pre-written remarks could be released earlier, possibly around 8:30AM ET, setting the tone for the session. We'll also hear from Fed officials Hammack and Williams, adding to the market&#8217;s focus on rate expectations. Additionally, a 3-Year Note Auction from the Treasury at 1PM ET could provide insights into bond market sentiment. With volatility likely, traders should be prepared for rapid moves and manage risk accordingly. Stay frosty and trade with caution. Good luck!
The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.
Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day—hours before it&#8217;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.

Equities

Technicals

Market Clubhouse Morning Memo - February 11th, 2025 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META and TSLA)

SIDU

Sidus Space Completion Integration With LizzieSat-3 Launch Vehicle At Astrotech Space Operations Facility

MYTE

MYT Netherlands Parent B.V. shares are trading higher after the company reported better-than-expected Q2 financial results.

Exelon Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) will release its fourth-quarter financial results before the <a href="https://www.benzinga.com/quote/EXC/earnings">opening bell on Wednesday.</a>
Analysts expect the Chicago-based company to report quarterly earnings at 59 cents per share, down from 60 cents per share in the year-ago period. Exelon projects quarterly revenue of $4.74 billion, compared to $5.37 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 21, Evercore ISI Group analyst Durgesh Chopra upgraded Exelon from In-Line to Outperform and raised the price target from $43 to $44.
With the recent buzz around Exelon, some investors may be eyeing potential gains from the company's dividends too. As of now, Exelon offers an annual dividend yield of 3.64%, which is a quarterly dividend amount of 38 cents per share ($1.52 a year).
To figure out how to earn $500 monthly from Exelon, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Exelon's $1.52 dividend: $6,000 / $1.52 = 3,947 shares.
So, an investor would need to own approximately $164,985 worth of Exelon, or 21,429 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.52 = 789 shares, or $32,980 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
EXC Price Action: Shares of Exelon gained by 1.2% to close at $41.80 on Monday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>
Photo: Shutterstock

Earnings

Long Ideas

Markets

Trading Ideas

How To Earn $500 A Month From Exelon Stock Ahead Of Q4 Earnings

CMCO

Columbus McKinnon shares are trading lower after DA Davidson downgraded the stock from Buy to Neutral and announced a $35 price target.

PMEC

Primech AI Signs Three Pilot Program Agreements For HYTRON Cleaning Robot With Cleaning Companies

MAMO

Massimo Moves MVR Golf Cart Production To U.S

INSP

Inspire Medical Systems shares are trading lower after Baird, Morgan Stanley, and Wells Fargo cut their respective price targets on the stock.

NIPG

NIP Group shares are trading higher after the company announced it entered into a strategic partnership with Optics Valley Traffic.

Offerings

LIXTE Announces Purchase And Sale Of 434,784 Shares At $2.415 Each In Registered Direct Offering With Proceeds Expected To Be ~$1.05M

Dear Lakeland Shareholders,
Lakeland Fire + Safety's fiscal year 2025, which ended January 31st, was a transformative year in many ways, underscored by multiple successful acquisitions to build a head-to-toe portfolio of brands in fire protection, new management, and an improved capital position to fund our long-term initiatives. To that end, we most recently closed an oversubscribed $46.0 million public equity offering, which brought in an impressive pool of new and existing shareholders. This secondary offering strengthened our balance sheet and positioned us to accelerate further growth in the fragmented, higher margin, $2.0 billion fire protection sector in the largest global markets and to repay indebtedness, resulting in an expected cash interest savings of approximately $2.5 million annually. With this strong vote of confidence from investors, we are moving forward into Fiscal Year 2026 by continuing to implement strategies to accelerate growth and margins by renewing our acquisition focus on the fire turnout gear industry and specifically the decontamination and services segment, which offers recurring high margin revenue streams. While we believe we now have the full suite of premier global head-to-toe fire services products, we are also not ruling out other opportunities, including joint ventures or affiliations in fire and the industrial space and opportunistic M&amp;A in the high-margin chemical space within our industrial offerings. We continue to see growth opportunities in the fire and the industrial space, as well as opportunistic M&amp;A in the high-margin chemical space within our industrial offerings, where we can purchase businesses for fair EBITDA multiples and integrate and deliver higher financial returns on our revamped platform. We have demonstrated our success with our last four acquisitions, providing confidence in our roll-up strategy, and we now have ample capital and flexibility to execute this strategy.
In the past year, we have completed four accretive acquisitions that added product line extensions and innovative new products and expanded our global markets, channels, and customers. These strategic acquisitions are a part of our initiative to build a portfolio of premier global fire brands under Lakeland Fire + Safety in this fragmented market. These highly innovative and customer-focused organizations are outstanding brands with high quality products and relatively low purchase price multiples, and they provide us with attractive cross-selling opportunities globally. They each have complementary product lines to Lakeland's existing portfolio that greatly benefit our product offering, particularly within fire service protective clothing. Together, the acquisitions have expanded our footprint in North America, Europe, Asia, Oceania, LATAM, and the Middle East with strategic distributors and partnerships in each region.
Late in 2023, we announced the acquisition of New Zealand-based Pacific Helmets NZ Limited, a leading designer and manufacturer of helmets for structural firefighting, wildland firefighting, and rescue markets. Pacific Helmet's premium product line has a global reputation for safety and design, complements the existing Lakeland turnout gear offering, and provides attractive cross-selling opportunities globally, especially in the U.S.
Early in 2024, we acquired Jolly Scarp, a leading designer and manufacturer of professional footwear for the firefighting, military, police, and rescue markets. The company is headquartered in the renowned shoe design area of Montebelluna, Italy, with manufacturing operations in Bucharest, Romania. Jolly's strong brand has a well-established reputation for quality and innovative professional footwear design and manufacturing in the growing first responder safety market.
LHD Group Deutschland GmbH (LHD) and its Hong Kong and Australian subsidiaries were acquired in July and are leaders in firefighter turnout gear, accessories, and decontamination services, including laundry, repair, and maintenance. LHD has established a significant market presence with premium fire services products across Germany and Australia, two of the largest firefighter markets in the world, and the leading position in Hong Kong. The Lakeland LHD Care protective clothing maintenance segment ensures the longevity and effectiveness of firefighting gear and is an attractive recurring revenue stream.
In December we completed our fourth acquisition, Veridian, a leading provider of firefighter protective apparel, including fire and rescue garments, gloves, and boots. Veridian's strong brand and complementary fire services products significantly strengthen our competitive positioning and deliver immediate market share gains in the U.S. and Latin America.
To support our acquisitions and fuel growth, Roger Shannon, CFO, Helena An, COO, and I welcomed new, experienced executives to the management team. This experienced management team has each executed strategies like Lakeland's - a turnaround/efficiency focus with accretive acquisitions and synergies to accelerate growth and create value. To drive our sales initiatives, we appointed two distinguished sales professionals: Barry Phillips as Chief Revenue Officer and Cameron Stokes to the newly created role of Chief Commercial Officer, Global Industrial. Barry brings over 37 years of experience in global sales leadership, revenue growth, and strategic market development, particularly in the fire services sector. Cameron is a seasoned sales and marketing executive focusing on driving multimillion-dollar revenue growth and expanding market share in industrial safety products.
Focusing on our expanding global workforce, we appointed Laurel Yartz as Chief Human Resources Officer. Laurel brings over 30 years of experience in global Human Resources leadership, primarily in Fortune 500 and private equity companies. Her extensive background includes senior strategic roles leading cultural and business transformation. As CHRO, she is responsible for enhancing Lakeland's people strategy and fostering a culture focused on growth, innovation, flawless execution, customer satisfaction, and continuous improvement.
Finally, I was privileged to be one of the new appointments after serving as Executive Chairman of the Board since August 2023 and as a director since 2012. Throughout my tenure and moving forward, I am committed to executing our strategy to build a premier global fire services brand and drive profitable growth in our other strategic product lines through product management, product development, channel diversification, and operations optimization.
Looking back over the past year, we have now successfully positioned Lakeland Fire + Safety for the future, bringing together the people, companies, products and capital to accelerate growth opportunities and increase market penetration. As we now look ahead, we are focused on new M&amp;A opportunities to further consolidate the fragmented fire market with the newly raised capital and Lakeland's accelerating free cash flow to support this acquisition strategy. We are growing top-line revenue in our fire services and industrial verticals, combined with operating and manufacturing efficiencies, to achieve higher margins. All together, we could not be more excited for Fiscal Year 2026 and expect to grow faster than the markets we serve. I look forward to sharing exciting new milestones in the year to come.
Sincerely,
Jim Jenkins President, Chief Executive Officer and Executive Chairman

LAKE

Lakeland Industries President, CEO And Chairman, Jim Jenkins, Issues Letter To Shareholders

In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report), wi...

H.C. Wainwright Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)

Barclays analyst Gena Wang maintained a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of $45.00. Th...

4D Molecular Therapeutics (FDMT) Receives a Buy from Barclays

Analyst Matthew Caufield of H.C. Wainwright reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report), retaining the price targ...

4D Molecular Therapeutics: Strong Buy Rating on Promising 4D-150 Gene Therapy Data and Strategic Phase 3 Trials

In a report released yesterday, Kostas Biliouris from BMO Capital maintained a Hold rating on 4D Molecular Therapeutics (FDMT – Research Report), w...

Cautious 'Hold' Rating on 4D Molecular Therapeutics Amidst Competitive Market and Investor Concerns

4D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend's Angiogenesis, Exudation, and Degener...

4D Molecular's wAMD drug is best-in-class, says RBC, sees 'ideal' entry point

RBC Capital analyst Lisa Walter reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of $39.0...

4D Molecular Therapeutics (FDMT) Gets a Buy from RBC Capital

In a report released yesterday, Geulah Livshits from Chardan Capital maintained a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report),...

Chardan Capital Keeps Their Buy Rating on 4D Molecular Therapeutics (FDMT)

Chardan lowered the firm's price target on 4D Molecular (FDMT) to $30 from $39 but keeps a Buy rating on the shares following the company's interim...

4D Molecular price target lowered to $30 from $39 at Chardan

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pacific Biosciences (PACB – Research Report), Immu...

Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Immunovant (IMVT) and 4D Molecular Therapeutics (FDMT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and 4D Mol...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and 4D Molecular Therapeutics (FDMT)

ADVM

FDMT

GMED

IMVT

PACB

Press Releases

4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV

Health Care

4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS

4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway

4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. - FDMT

4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. - FDMT

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

Abeona Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Comments

4D Molecular Therapeutics

Actualités

Dernières nouvelles pour 4D Molecular Therapeutics (NASDAQ:FDMT) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL